|This article is an orphan, as no other articles link to it. Please introduce links to this page from ; try the Find links tool for suggestions. (February 2009)|
James Maryanski (born ) is the Biotechnology Coordinator for the Food and Drug Administration's Center for Food Safety and Applied Nutrition. He began working for the FDA in 1977 and became acting Coordinator for biotechnology policy in 1986.
Maryanski received a BSc in microbiology from Ohio State University, in 1965 after which he was briefly employed by the US Public Health Service in Ohio. Maryanski received a PhD in 1972 from the University of New Hampshire where he had studied microbiology, molecular biology, and marine science.
He then spent four years at the National Institute for Dental Research, of the National Institutes of Health, investigating carbohydrate transport and cell adhesion in dental micro-organisms. Dr Maryanski regularly serves as an expert consultant on food biotechnology representing the FDA in varying capacities.
Focus on genetically modified food
Maryanski has spoken sidely on genetically modified food and medicine. He has championed Calgene's Flavr Savr tomato and other genetically modified food products, noting that all crops have been subject to some form of genetic modification, either through traditional methods or newer techniques of isolating specific genes.
He has received the FDA Commissioner's Special Citation and Commendable Service Awards for his work in food biotechnology.
1999 testimony on GMO safety